Early research (Phase 1)Ended earlyNCT01013831
What this trial is testing
Erlotinib Hydrochloride in Preventing Cancer in Patients With Precancerous Lesions of the Lung
Who this might be right for
DysplasiaMetaplasiaPulmonary Precancerous Condition
National Cancer Institute (NCI) 60